Page last updated: 2024-12-07
2,3-dihydroquinolin-4(1h)-one
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2,3-dihydroquinolin-4(1H)-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 117158 |
CHEMBL ID | 4584531 |
SCHEMBL ID | 68581 |
MeSH ID | M0541323 |
Synonyms (32)
Synonym |
---|
OPREA1_697248 |
2,3-dihydro-4(1h)-quinolinone |
1,2,3,4-tetrahydroquinolin-4-one |
OPREA1_507697 |
2,3-dihydro-1h-quinolin-4-one |
4295-36-7 |
AKOS000281769 |
2,3-dihydro-1h-quinolin-4-one;2,3-dihydroquinolin-4(1h)-one |
A826081 |
2,3-dihydroquinolin-4(1h)-one |
FT-0602201 |
AB06711 |
SCHEMBL68581 |
2,3-dihydroquinolin-4(1 h)-one |
BUWPZNOVIHAWHW-UHFFFAOYSA-N |
4-oxo-1,2,3,4-tetrahydroquinoline |
2,3-dihydro-4-quinolone |
1,2,3,4-tetrahydro-4-quinolinone |
AC-29666 |
mfcd00666394 |
4(1h)-quinolinone, 2,3-dihydro- |
J-506991 |
DTXSID30276195 |
CS-W005292 |
2,3-dihydro-1h-quinolin-4-one, aldrichcpr |
DS-17151 |
BCP10083 |
EN300-80423 |
SY029732 |
2,3-dihydro-4-hydroxyquinoline |
CHEMBL4584531 |
D5773 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 21.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.85) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |